329 related articles for article (PubMed ID: 8060769)
1. Primary hyperparathyroidism and parathyroid hormone-related protein.
Horwitz MJ; Bilezikian JP
Curr Opin Rheumatol; 1994 May; 6(3):321-8. PubMed ID: 8060769
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone-related protein, parathyroid hormone, and vitamin D in hypercalcemia of malignancy.
Motellón JL; Javort Jiménez F; de Miguel F; Jaras MJ; Díaz A; Hurtado J; Esbrit P
Clin Chim Acta; 2000 Jan; 290(2):189-97. PubMed ID: 10660809
[TBL] [Abstract][Full Text] [Related]
4. [The role of a parathyroid hormone analogue in the pathogenesis of malignant hypercalcemia].
Rizzoli R; Buchs B; Pizurki L; Caverzasio J; Sappino AP; Vadas L; Arlot M; Bonjour JP
Pathol Biol (Paris); 1990 Jun; 38(6):656-64. PubMed ID: 2197594
[TBL] [Abstract][Full Text] [Related]
5. Hyperparathyroidism, humoral hypercalcemia of malignancy, and the anabolic actions of parathyroid hormone and parathyroid hormone-related protein on the skeleton.
Stewart AF
J Bone Miner Res; 2002 May; 17(5):758-62. PubMed ID: 12009005
[TBL] [Abstract][Full Text] [Related]
6. Immunoassays for parathyroid hormone 1-84 in the diagnosis of hyperparathyroidism.
Nussbaum SR; Potts JT
J Bone Miner Res; 1991 Oct; 6 Suppl 2():S43-50; discussion S61. PubMed ID: 1722383
[TBL] [Abstract][Full Text] [Related]
7. Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with multiple endocrine neoplasia type 1.
Milanesi A; Yu R; Geller SA; Burton D; Deftos LJ; Wolin EM
Pancreas; 2011 May; 40(4):634-7. PubMed ID: 21483254
[TBL] [Abstract][Full Text] [Related]
8. Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia.
Ratcliffe WA; Hutchesson AC; Bundred NJ; Ratcliffe JG
Lancet; 1992 Jan; 339(8786):164-7. PubMed ID: 1346019
[TBL] [Abstract][Full Text] [Related]
9. Hypercalcemia in cancer.
Martin TJ; Grill V
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):123-9. PubMed ID: 1525053
[TBL] [Abstract][Full Text] [Related]
10. Clinical practice. Asymptomatic primary hyperparathyroidism.
Bilezikian JP; Silverberg SJ
N Engl J Med; 2004 Apr; 350(17):1746-51. PubMed ID: 15103001
[No Abstract] [Full Text] [Related]
11. [Hypercalcemia - Diagnosis and Management].
Koster M; Brändle M
Praxis (Bern 1994); 2022 Sep; 111(12):675-681. PubMed ID: 36102025
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism of action of parathyroid hormone related peptide in hypercalcemia of malignancy: therapeutic strategies (review).
Rabbani SA
Int J Oncol; 2000 Jan; 16(1):197-206. PubMed ID: 10601566
[TBL] [Abstract][Full Text] [Related]
13. Hypercalcemia and parathyroid disorders.
Endres DB
Curr Opin Rheumatol; 1992 Jun; 4(3):383-8. PubMed ID: 1599819
[TBL] [Abstract][Full Text] [Related]
14. [Performances of two kits for parathyroid hormone-related peptide (PTHrP) assay in the additional study of malignant hypercalcemias].
Minebois-Villegas A; Audran M; Lortholary A; Legrand E; Boux De Casson-Raimbeau F; Jallet P
Pathol Biol (Paris); 1995 Nov; 43(9):799-805. PubMed ID: 8746102
[TBL] [Abstract][Full Text] [Related]
15. Hypercalcemia with low-normal serum intact PTH: a novel presentation of primary hyperparathyroidism.
Hollenberg AN; Arnold A
Am J Med; 1991 Nov; 91(5):547-8. PubMed ID: 1951417
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer associated with hypercalcemia induced by concurrently elevated parathyroid hormone and parathyroid hormone-related protein levels.
Uchimura K; Mokuno T; Nagasaka A; Hayakawa N; Kato T; Yamazaki N; Kobayashi T; Nagata M; Kotake M; Itoh M; Tsujimura T; Iwase K
Metabolism; 2002 Jul; 51(7):871-5. PubMed ID: 12077733
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations.
Walls J; Ratcliffe WA; Howell A; Bundred NJ
Clin Endocrinol (Oxf); 1994 Oct; 41(4):407-13. PubMed ID: 7955450
[TBL] [Abstract][Full Text] [Related]
18. Primary hyperparathyroidism or hypercalcaemia of malignancy?
Birkeland KI; Gallefoss F; Olsson S; Haug E
Scand J Clin Lab Invest; 1992 Jun; 52(4):347-9. PubMed ID: 1439519
[TBL] [Abstract][Full Text] [Related]
19. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
[TBL] [Abstract][Full Text] [Related]
20. Circulating levels of midregional parathyroid hormone-related protein in hypercalcaemia of malignancy.
Blind E; Raue F; Götzmann J; Schmidt-Gayk H; Kohl B; Ziegler R
Clin Endocrinol (Oxf); 1992 Sep; 37(3):290-7. PubMed ID: 1424212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
